Tactile Systems Technology Inc (NASDAQ:TCMD) Director Richard Nigon sold 5,354 shares of the company’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of $49.30, for a total value of $263,952.20. Following the completion of the transaction, the director now owns 21,368 shares of the company’s stock, valued at $1,053,442.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Richard Nigon also recently made the following trade(s):
- On Wednesday, September 4th, Richard Nigon sold 39 shares of Tactile Systems Technology stock. The stock was sold at an average price of $49.35, for a total value of $1,924.65.
Shares of TCMD stock traded up $0.06 on Wednesday, reaching $50.49. 167,113 shares of the stock were exchanged, compared to its average volume of 235,220. The company has a quick ratio of 4.34, a current ratio of 5.04 and a debt-to-equity ratio of 0.02. The stock has a market cap of $949.60 million, a P/E ratio of 148.50, a price-to-earnings-growth ratio of 4.14 and a beta of 2.06. The firm has a 50 day moving average of $51.25 and a two-hundred day moving average of $54.74. Tactile Systems Technology Inc has a 1-year low of $37.40 and a 1-year high of $76.63.
A number of brokerages have issued reports on TCMD. Zacks Investment Research lowered Tactile Systems Technology from a “buy” rating to a “hold” rating in a research note on Tuesday, August 20th. BTIG Research raised shares of Tactile Systems Technology from a “neutral” rating to a “buy” rating and set a $62.00 price objective for the company in a research note on Wednesday, August 7th. BidaskClub lowered shares of Tactile Systems Technology from a “hold” rating to a “sell” rating in a report on Friday, July 19th. ValuEngine raised shares of Tactile Systems Technology from a “hold” rating to a “buy” rating in a research report on Thursday, August 1st. Finally, Dougherty & Co initiated coverage on shares of Tactile Systems Technology in a research report on Thursday, June 13th. They issued a “buy” rating and a $80.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $73.29.
Large investors have recently made changes to their positions in the business. Capital Fund Management S.A. grew its holdings in Tactile Systems Technology by 91.7% during the second quarter. Capital Fund Management S.A. now owns 18,400 shares of the company’s stock valued at $1,047,000 after purchasing an additional 8,800 shares during the period. Great Lakes Advisors LLC acquired a new position in shares of Tactile Systems Technology during the 1st quarter worth approximately $2,615,000. AWM Investment Company Inc. increased its position in shares of Tactile Systems Technology by 8.0% during the 2nd quarter. AWM Investment Company Inc. now owns 134,714 shares of the company’s stock worth $7,668,000 after purchasing an additional 10,000 shares during the last quarter. Los Angeles Capital Management & Equity Research Inc. raised its stake in shares of Tactile Systems Technology by 689.3% during the 2nd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 44,278 shares of the company’s stock worth $2,520,000 after purchasing an additional 38,668 shares in the last quarter. Finally, Janus Henderson Group PLC raised its stake in shares of Tactile Systems Technology by 5.9% during the 2nd quarter. Janus Henderson Group PLC now owns 889,025 shares of the company’s stock worth $50,603,000 after purchasing an additional 49,721 shares in the last quarter. Institutional investors own 99.67% of the company’s stock.
About Tactile Systems Technology
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices for the treatment of chronic diseases in the United States. The company offers Flexitouch system, an at-home solution for lymphedema patients; and ACTitouch system, a home-based solution for chronic venous insufficiency patients.
Featured Article: What is the significance of the death cross?
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.